$2.38T
Total marketcap
$82.13B
Total volume
BTC 50.16%     ETH 15.30%
Dominance

Bionik Laboratories BNKL Stock

0 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
12 USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
1K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.72 USD

Bionik Laboratories Price Chart

Bionik Laboratories BNKL Financial and Trading Overview

Bionik Laboratories stock price 0.0000 USD
Previous Close 0.64 USD
Open 0.54 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.54 - 0.54 USD
52 Week Range 0.25 - 2.9 USD
Volume 1.11K USD
Avg. Volume 3.05K USD
Market Cap 3.71M USD
Beta (5Y Monthly) -1.229225
PE Ratio (TTM) N/A
EPS (TTM) -0.72 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BNKL Valuation Measures

Enterprise Value 5.65M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.4838371
Price/Book (mrq) N/A
Enterprise Value/Revenue 3.779
Enterprise Value/EBITDA -1.16

Trading Information

Bionik Laboratories Stock Price History

Beta (5Y Monthly) -1.229225
52-Week Change -45.99%
S&P500 52-Week Change 20.43%
52 Week High 2.9 USD
52 Week Low 0.25 USD
50-Day Moving Average 0.47 USD
200-Day Moving Average 0.47 USD

BNKL Share Statistics

Avg. Volume (3 month) 3.05K USD
Avg. Daily Volume (10-Days) 18.07K USD
Shares Outstanding 6.88M
Float 3.22M
Short Ratio N/A
% Held by Insiders 61.64%
% Held by Institutions 1.18%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:150

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End March 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -329.63%
Gross Margin 58.07%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -63.74%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 1.5M USD
Revenue Per Share (ttm) 0.23 USD
Quarterly Revenue Growth (yoy) 213.79%
Gross Profit (ttm) 953.26K USD
EBITDA -4872712 USD
Net Income Avi to Common (ttm) -5294980 USD
Diluted EPS (ttm) -1.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 685.2K USD
Total Cash Per Share (mrq) 0.1 USD
Total Debt (mrq) 1.86M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.47
Book Value Per Share (mrq) -0.076

Cash Flow Statement

Operating Cash Flow (ttm) -4010251 USD
Levered Free Cash Flow (ttm) -2178075 USD

Profile of Bionik Laboratories

Country United States
State MA
City Watertown
Address 80 Coolidge Hill Road
ZIP 02472
Phone 617 926 4800
Website https://www.bioniklabs.com
Industry Medical Care Facilities
Sector(s) Healthcare
Full Time Employees 12

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Q&A For Bionik Laboratories Stock

What is a current BNKL stock price?

Bionik Laboratories BNKL stock price today per share is 0.0000 USD.

How to purchase Bionik Laboratories stock?

You can buy BNKL shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bionik Laboratories?

The stock symbol or ticker of Bionik Laboratories is BNKL.

Which industry does the Bionik Laboratories company belong to?

The Bionik Laboratories industry is Medical Care Facilities.

How many shares does Bionik Laboratories have in circulation?

The max supply of Bionik Laboratories shares is 0.

What is Bionik Laboratories Price to Earnings Ratio (PE Ratio)?

Bionik Laboratories PE Ratio is now.

What was Bionik Laboratories earnings per share over the trailing 12 months (TTM)?

Bionik Laboratories EPS is -0.72 USD over the trailing 12 months.

Which sector does the Bionik Laboratories company belong to?

The Bionik Laboratories sector is Healthcare.